We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Neutropenia Found in Congenital and Adult Babesiosis

By LabMedica International staff writers
Posted on 24 Aug 2015
Anemia and thrombocytopenia are expected hematologic abnormalities in patients with acute babesiosis, whereas neutropenia is not usually considered a feature of this infection. More...


Babesiosis is a parasitic disease caused by intraerythrocytic protozoa of the Babesia genus such as Babesia microti as well as other species. Babesia are transmitted in nature through the bites of infected ticks, but can also be acquired through contaminated blood components from asymptomatic parasitemic donors or, more rarely, transplacentally.

Scientists at the New York Medical College (Valhalla, NY, USA) determined the frequency of neutropenia in cases of congenital babesiosis based on a literature review and on the findings in an unreported case. The frequency of neutropenia in adult patients was assessed based on a review of the medical records of 51 patients who were diagnosed with babesiosis between 2010 and 2013 at two medical centers in the Northeastern United States.

Neutropenia was defined as an absolute neutrophil count of less than or equal to 1,800 neutrophils/μL for adults and less than 1,200 neutrophils/μL for infants. Four of five infants with congenital babesiosis whose neutrophil count was reported were neutropenic. Among 51 adult cases with babesiosis, 11 were neutropenic on clinical presentation, and 7 others developed neutropenia over the next 1 to 21 days. Consequently, a total of 18 (35%) of the adult patients with babesiosis had neutropenia.

The authors concluded that neutropenia appears to be a common finding in infants with congenital babesiosis and is also observed not infrequently in adults with this infection. The study was published in the September 2015 issue of the American Journal of Clinical Pathology.

Related Links:

New York Medical College



Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.